Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, Calvisi DF, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall TJ, Khan SA, Klümpen HJ, Koerkamp BG, Lamarca A, Lindsey S et al. (2025)
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Nat Rev Gastroenterol Hepatol (in press)
DOI 10.1038/s41575-025-01153-w, PubMed 41372578

Breder S, Villard C, Eide E, Wang B, Engesæter LK, Reims HM, Hov JR, Melum E, Aabakken L, Line PD, Lømo J, Grzyb K, Wiencke K, Bergquist A, Folseraas T (2025)
A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits
JHEP Rep, 7 (12), 101598
DOI 10.1016/j.jhepr.2025.101598, PubMed 41321929

Del Zompo F, Crouchet E, Ostyn T, Nehme Z, Messé M, Jühling F, Désert R, Vieira AT, Moehlin J, Nakib D, Andrews T, Perciani C, Chung S, Bader GD, McGilvray I, Caime C, Scaravaglio M, Carbone M, Invernizzi P, Yaqub S, Folseraas T, Karlsen TH, Shankar G, Primeaux M, Dhawan P et al. (2025)
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis
J Hepatol, 83 (6), 1305-1319
DOI 10.1016/j.jhep.2025.08.005, PubMed 40846184